Our 5th Oxford meeting – Aptamers 2018 – will address therapeutic, diagnostic, analytical and basic research applications of aptamers and invites oral and poster abstracts from academic and industrial researchers. We particularly encourage final year doctoral students and early/mid career postdoctoral researchers/junior group leaders to submit oral abstracts, as we believe this event will provide their research excellent exposure, critical analysis by attending senior researchers and new career opportunities.
The symposium will feature:
High-impact talks, discussions & several hours of networking
Oral presentations by an international faculty of senior & junior researchers from academia & industry
Update on aptamer patents
Posters, plus flash talks by selected poster presenters
Excellent networking opportunities, & a relaxed and friendly environment
Aptamers 2018 will be co-hosted with Oligo 2018 (10th April) – 4th symposium on antisense & therapeutic oligonucleotides (separate registration required).
Oxford Global Conferences are proud to present the 5th Annual Biosimilars & Biobetters Congress co-located with the 11th Annual Proteins & Antibodies Congress and the 5th Annual Peptides Congress, taking place on the 16-17 April 2018 in London.
Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions
Over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics
Two-day interactive conference addressing the following topics:
View Agenda here: http://bit.ly/2eFkKL6
Biosimilars: Everyday Practice, Manufacturing Pre-Clinical Trials
Hosted by Katalin Egyed, International Oncology and Onco-biotechnology Business Unit Manager, EGIS Pharmaceuticals and Rafał Derlacz, Senior Project Manager, Polpharma.
Wednesday 7th February 2018 | 10am GMT
Register today for free: http://bit.ly/2xNJGbG
Biosimilars: The Cancer Patient Perspective
Hosted by Lydia Makaroff, Director, European Cancer Patient Coalition
Tuesday 13th February 2018 | 10am GMT
Register today for free: http://bit.ly/2j1vAAf
Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.
For further information, prices & discounts please contact email@example.com
Meet Us at The 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018) (Booth # 319), Anaheim, CA, USA, 13–16 May 2018
We will be attending The 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018), co-located with the TechConnect World Innovation Conference, Defense TechConnect Summit and Spring SBIR/STTR Conference. The event will attract more than 350 featured exhibitors and an expected crowd of more than 4000 attendees, including business executives, venture capitalists, politicians, s cientists and researchers from over 70 countries. Nanotech contains 38 symposiums and brings together specialists from a wide range of scientific fields, technology and business.
Representatives of the following open access journals will attend:
Journal of Functional Biomaterials
Journal of Imaging
Journal of Low Power Electronics and Applications
International Journal of Environmental Research and Public Health
Journal of Manufacturing and Materials Processing
If you will also attend this conference, please feel free to stop by our booth (Booth # 319). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit:
The XXV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2018) will be organised by the Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society (SFD), on behalf of the European Federation for Medicinal Chemistry (EFMC).
The EFMC is the main organisation for European Medicinal Chemistry community, with 27 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in its field and attracts traditionally around 1200 participants, from industry and academia. Recent EFMC-ISMC meetings have taken place in Belgium (Brussels, 2010), Germany (Berlin, 2012), Portugal (Lisbon, 2014) and most recently in the United Kingdom (Manchester, 2016).
The symposium will take place in Ljubljana from September 2-6, 2018.
The 2018 edition will continue the tradition established by these biennial symposia of covering drug discovery advances in major therapeutic areas, including the treatment of inflammatory and autoimmune diseases, infectious diseases including fungal infections, cardiometabolic diseases, neurodegenerative diseases and oncology. EFMC-ISMC 2018 will present the most recent advances in up-to-date topics like protein degradation, STING pathway, kinetics and pharmacokinetics of drug binding and PET imaging, and will tackle some out-of-the-box areas of Medicinal Chemistry including carbohydrate-based vaccines and new chemical modalities, while Chemical Biology approaches to target identification will cover the interfaces between chemistry, biology and experimental medicine. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of artificial intelligence in drug discovery.
Il XXXVIII Convegno Nazionale della Divisione di Chimica Organica della Società Chimica Italiana si svolgerà a Milano dal 9 al 13 settembre 2018. L’organizzazione di questa edizione del Convegno è curata dalla Divisone di Chimica Organica della Società Chimica Italiana con il supporto dell’Università degli Studi di Milano e dell’Università degli Studi di Milano-Bicocca, e con la collaborazione di Federchimica e Assolombarda.
Il Convegno, come da tradizione, è aperto all’accademia, agli enti di ricerca, all’industria, alla scuola ed alle istituzioni attive in tutti i settori della chimica organica ed in quelli interdisciplinari ad essa collegati, con lo scopo di stimolare discussioni e promuovere proficui scambi scientifici.